MOL3655 Simplexa VZV Swab Direct - Product Usage: is intended for use on the LIAISON MDX instrume...

FDA Device Recall #Z-2549-2020 — Class II — May 12, 2020

Recall Summary

Recall Number Z-2549-2020
Classification Class II — Moderate risk
Date Initiated May 12, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm DiaSorin Molecular LLC
Location Cypress, CA
Product Type Devices
Quantity 304 plastic vials (24 vials per box)

Product Description

MOL3655 Simplexa VZV Swab Direct - Product Usage: is intended for use on the LIAISON MDX instrument for the qualitative detection of varicella-zoster virus (VZV) DNA present in cutaneous and mucocutaneous lesion swabs from patients with signs and symptoms of VZV infection.

Reason for Recall

Due to a software malfunction in the Multi Assay Suite, there is the probability of increased occurrence of false negative results.

Distribution Pattern

Worldwide distribution - U.S. Nationwide distribution including in the states of CO, FL, KS, MI, NC, PA, TX, and WA The countries of Austria, Czech Republic, France and Switerland.

Lot / Code Information

MOL3655 Simplexa VZV Swab Direct: Lot Numbers Release Date Exp Date 5743N 09/11/19 9/30/2020 5819N 10/09/19 10/31/2020 5820N 02/14/20 2/28/2021

Other Recalls from DiaSorin Molecular LLC

Recall # Classification Product Date
Z-2153-2023 Class II Simplexa Direct Amplification Disc Kit, Rx Only... Jun 14, 2023
Z-1209-2023 Class II Simplexa COVID-19 Direct, REF: MOL4150; includi... Jan 30, 2023
Z-1210-2023 Class II Simplexa Flu A/B & RSV Direct Gen II, REF: MOL2... Jan 30, 2023
Z-0457-2022 Class II Simplexa Direct Amplification Disc Kit, Product... Nov 19, 2021
Z-0162-2022 Class II SIMPLEXA COVID-19 Positive Control Pack, REF MO... Sep 23, 2021

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.